A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients

Figure 5

(a) Prognostic nomogram for liver cancer patients. (b–d) OS prediction at 1, 2, and 3 years by the corrected curve of the nomogram. (e, f) Area under the curve of time-dependent ROC curves in the ICGC cohort. Time-dependent ROC for 1-year, 2-year, and 3-year OS of the nomogram in the TCGA (e) and in the ICGC (f).

(a)

(b)

(c)

(d)

(e)

(f)